Form 4: Syndax Pharmaceuticals CEO Sells Shares for Tax Obligations
Insider Transaction Report
Syndax Pharmaceuticals Inc. CEO Michael A. Metzger sold 7,534 shares of common stock at $9.285 per share to cover tax withholding obligations related to restricted stock unit vesting.
Summary
- Michael A. Metzger, Chief Executive Officer and Director of Syndax Pharmaceuticals Inc. (SNDX), sold 7,534 shares of the company's common stock.
- The transaction occurred on July 16, 2025, with shares sold at a price of $9.285 per share.
- The sale was conducted to cover tax withholding obligations associated with the vesting of restricted stock units.
- Following this transaction, Michael A. Metzger directly beneficially owns 298,661 shares of Syndax Pharmaceuticals Inc. common stock.
Sentiment
Score: 5
Explanation: The transaction is a routine sale to cover tax obligations from restricted stock unit vesting, which is a neutral event and does not indicate a change in management's outlook or company performance.
Future Outlook
No forward-looking statements or guidance are provided in this Form 4 filing, as it pertains solely to an insider transaction.
Industry Context
This Form 4 filing details a routine insider transaction for tax purposes and does not provide broader industry context or trends. It is specific to the individual's compensation and tax obligations within Syndax Pharmaceuticals Inc.
Stakeholder Impact
- Shareholders: The sale is a routine tax-related transaction and is unlikely to have a significant direct impact on shareholders beyond the minor dilution from the shares being sold into the market. It does not signal a change in management's confidence.
Key Dates
| Date | Description |
|---|---|
| 07/16/2025 | Date of transaction (sale of common stock). |
| 07/18/2025 | Date the Form 4 was signed by the reporting person. |
Keywords
Syndax Pharmaceuticals, SNDX, SEC Form 4, Insider Trading, Stock Sale, Tax Withholding, Restricted Stock Units, CEO, Michael A. Metzger
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.